• Privacy Policy
  • Terms and Conditions
  • Contact
Monday, August 3, 2026
Pharma Info Nepal
  • Home
  • Vacancy
  • Courses
  • License
  • Loksewa
  • Questions
  • Downloads
  • Pharmacy Books
    • Pharmacy Act and Guidelines
    • Study Materials
  • Pharmacy Notes
    • B Pharmacy
    • D Pharmacy
No Result
View All Result
  • Home
  • Vacancy
  • Courses
  • License
  • Loksewa
  • Questions
  • Downloads
  • Pharmacy Books
    • Pharmacy Act and Guidelines
    • Study Materials
  • Pharmacy Notes
    • B Pharmacy
    • D Pharmacy
No Result
View All Result
Pharma Info Nepal
No Result
View All Result
Home Study Materials

Classification of Anti-Cancer Drugs

Classification of Anti-Cancer Drugs

Pharma Info Nepal by Pharma Info Nepal
August 3, 2026
in Study Materials
0
Classification of Anti-Cancer Drugs
21
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

Classification of Anti-Cancer Drugs

Classification of Anticancer Drugs: Types, Mechanism, Examples & Mnemonics

Cancer chemotherapy consists of a diverse group of drugs that destroy cancer cells through different mechanisms. Anticancer drugs are broadly classified into cytotoxic drugs, targeted therapy, and hormonal therapy. Understanding this classification is essential for B.Pharm, M.Pharm, Pharmacy License, Lok Sewa, and other competitive pharmacy examinations.

What are Anticancer Drugs?

ADVERTISEMENT

Anticancer drugs (antineoplastic drugs) are medications used to prevent, destroy, or inhibit the growth and spread of malignant (cancer) cells. These drugs may act by:

  • Damaging DNA
  • Inhibiting DNA/RNA synthesis
  • Preventing cell division
  • Blocking growth factor receptors
  • Modulating hormones responsible for tumor growth

 

Classification of Anti-Cancer Drugs

Classification of Anticancer Drugs

  1. Cytotoxic Drugs

Cytotoxic drugs directly kill rapidly dividing cells by interfering with DNA replication or cell division.

  1. Alkylating Agents

These drugs form covalent bonds with DNA, causing cross-linking and inhibition of DNA replication.

Nitrogen Mustards

  • Mechlorethamine
  • Cyclophosphamide
  • Ifosfamide
  • Chlorambucil
  • Melphalan

Ethylenimine

  • Thiotepa

Alkyl Sulfonate

  • Busulfan

Nitrosoureas

  • Carmustine
  • Lomustine

Triazines

  • Dacarbazine
  • Temozolomide

Methylhydrazine

  • Procarbazine
  1. Platinum Coordination Complexes

These agents act similarly to alkylating agents by producing DNA cross-links.

Examples:

  • Cisplatin
  • Carboplatin
  • Oxaliplatin
  1. Antimetabolites

Antimetabolites inhibit DNA synthesis by mimicking normal cellular metabolites.

Folate Antagonists

  • Methotrexate
  • Pemetrexed

Purine Antagonists

  • 6-Mercaptopurine
  • 6-Thioguanine
  • Azathioprine
  • Fludarabine

Pyrimidine Antagonists

  • 5-Fluorouracil (5-FU)
  • Capecitabine
  • Cytarabine
  1. Microtubule-Damaging Agents

These interfere with mitotic spindle formation during cell division.

Vinca Alkaloids

  • Vincristine
  • Vinblastine
  • Vinorelbine

Taxanes

  • Paclitaxel
  • Docetaxel

Others

  • Estramustine
  1. Topoisomerase Inhibitors

These inhibit enzymes involved in DNA replication.

Topoisomerase II Inhibitor

  • Etoposide

Topoisomerase I Inhibitors

  • Topotecan
  • Irinotecan
  1. Antitumor Antibiotics

These interfere with DNA and RNA synthesis.

Examples:

  • Actinomycin D
  • Doxorubicin
  • Daunorubicin
  • Epirubicin
  • Mitoxantrone
  • Bleomycin
  • Mitomycin C
  1. Miscellaneous Cytotoxic Drugs
  • Hydroxyurea
  • L-Asparaginase
  • Tretinoin
  • Arsenic Trioxide
  1. Targeted Therapy

Targeted drugs specifically attack molecular targets present in cancer cells while causing comparatively less damage to normal tissues.

Tyrosine Kinase Inhibitors (TKIs)

Examples:

  • Imatinib
  • Nilotinib

EGFR Inhibitors

Examples:

  • Gefitinib
  • Erlotinib
  • Cetuximab

Angiogenesis Inhibitors

Prevent formation of new blood vessels supplying tumors.

Examples:

  • Sunitinib
  • Bevacizumab

Proteasome Inhibitor

Example:

  • Bortezomib

Monoclonal Antibody

Example:

  • Rituximab
  1. Hormonal Therapy

Hormonal drugs are mainly used in hormone-dependent cancers such as breast and prostate cancer.

Glucocorticoids

  • Prednisolone

Selective Estrogen Receptor Modulators (SERMs)

  • Tamoxifen
  • Toremifene

Aromatase Inhibitors

  • Letrozole
  • Anastrozole
  • Exemestane

5α-Reductase Inhibitors

  • Finasteride
  • Dutasteride

Progestins

  • Hydroxyprogesterone acetate

Estrogens

  • Ethinyl Estradiol
  • Fosfestrol

Selective Estrogen Receptor Down-Regulator (SERD)

  • Fulvestrant

Antiandrogens

  • Flutamide
  • Bicalutamide

GnRH Analogues

  • Nafarelin
  • Leuprorelin
  • Triptorelin

Quick Summary 

Main Class Subclass Common Examples
Alkylating Agents Nitrogen mustards Cyclophosphamide, Ifosfamide
Platinum Compounds Platinum complexes Cisplatin, Carboplatin
Antimetabolites Folate, Purine, Pyrimidine antagonists Methotrexate, 5-FU
Microtubule Inhibitors Vinca alkaloids, Taxanes Vincristine, Paclitaxel
Topoisomerase Inhibitors Topo I & II Irinotecan, Etoposide
Antibiotics Anthracyclines & others Doxorubicin, Bleomycin
Targeted Therapy TKIs, EGFR inhibitors Imatinib, Gefitinib
Hormonal Therapy SERMs, Aromatase inhibitors Tamoxifen, Letrozole

Easy Mnemonic

“A PAT TAM H”

  • A – Alkylating agents
  • P – Platinum compounds
  • A – Antimetabolites
  • T – Topoisomerase inhibitors
  • T – Tubulin (Microtubule) inhibitors
  • A – Antitumor antibiotics
  • M – Miscellaneous drugs
  • H – Hormonal therapy

Important Examination Points

  • Cyclophosphamide is the most commonly used alkylating agent.
  • Cisplatin is highly effective against testicular and ovarian cancers.
  • Methotrexate is a folate antagonist.
  • 5-Fluorouracil is a pyrimidine analogue.
  • Vincristine causes peripheral neuropathy with minimal myelosuppression.
  • Paclitaxel stabilizes microtubules and prevents their depolymerization.
  • Doxorubicin is associated with dose-dependent cardiotoxicity.
  • Bleomycin primarily causes pulmonary fibrosis.
  • Imatinib is the drug of choice for chronic myeloid leukemia (CML).
  • Tamoxifen is widely used in estrogen receptor-positive breast cancer.
  • Letrozole and Anastrozole are first-line aromatase inhibitors in postmenopausal breast cancer.
  • Toxicity of Methotrexate is minimized by Leucovorin (Folinic acid)
  • Cyclophosphamide toxicity minimized by MESNA

Anticancer drugs are broadly classified into cytotoxic agents, targeted therapies, and hormonal therapies, each acting through distinct mechanisms to inhibit cancer growth. A clear understanding of their classification, mechanisms, and representative examples is essential for clinical practice and for success in pharmacy examinations such as the Nepal Pharmacy Council License Examination, Lok Sewa, B.Pharm, and M.Pharm entrance examinations. Mastering this classification also provides a strong foundation for studying individual anticancer drugs, their adverse effects, and therapeutic applications.

 



  • Classification of Antihypertensive Drugs
  • Classification of Antidepressant Drugs
  • Classification of Antiemetics Drugs
  • Classification of Antibiotics Based on Mechanism of Action

Pharmacy License Preparation Online Classes

 

Tags: Anti Cancer DrugsClassification of Anti-Cancer DrugsDrug ClassificationStudy Materials
Previous Post

Classification of Antihypertensive Drugs

Pharma Info Nepal

Pharma Info Nepal

Pharma Info Nepal is Nepal's leading pharmacy education and information platform, dedicated to pharmacists, pharmacy students, and healthcare professionals. We provide trusted pharmacy news, regulatory updates, NPC and Loksewa exam resources, verified job opportunities, scholarships, research insights, and professional guidance to support excellence in pharmacy practice and education.

Related Posts

Classification of Antihypertensive Drugs
Study Materials

Classification of Antihypertensive Drugs

August 2, 2026
Good Manufacturing Practice (GMP) and Elements of GMP
B Pharmacy

Good Manufacturing Practice (GMP) and Elements of GMP

July 29, 2026
Pharma Info Nepal Class
License

Demo Class Pharma Info Nepal

May 16, 2026
Updated Guidelines on the Treatment of Drug-Susceptible and Drug-Resistant TB
Downloads

Updated Guidelines on the Treatment of Drug-Susceptible and Drug-Resistant TB

February 10, 2026
Load More

Recommended

Classification of Anti-Cancer Drugs

Classification of Anti-Cancer Drugs

August 3, 2026
Classification of Antihypertensive Drugs

Classification of Antihypertensive Drugs

August 2, 2026
DDA Notice Regarding Submission of Additional Documents for Pharmacy Registration and Renewal

DDA Notice Regarding Submission of Additional Documents for Pharmacy Registration and Renewal

August 2, 2026
Nepal's Pharmaceutical Industry Roadmap: WHO GMP Certification and Domestic Medicine Production Targets

Nepal’s Pharmaceutical Industry Roadmap: WHO GMP Certification and Domestic Medicine Production Targets

August 1, 2026
DDA Nepal's Journey Toward a Stronger Drug Regulatory System: Targeting WHO Maturity Level 3 by 2027

DDA Nepal’s Journey Toward a Stronger Drug Regulatory System: Targeting WHO Maturity Level 3 by 2027

August 1, 2026
ADVERTISEMENT
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Instagram

About Pharma Info Nepal

Pharma Info Nepal is a dedicated platform led by Nabin Bista, focused on empowering pharmacy students and professionals in Nepal. We provide high-quality educational resources, exam preparation materials, and professional guidance for pharmacy licensure exams and beyond. Our mission is to uplift the pharmacy profession in Nepal by fostering knowledge, skills, and excellence in pharmaceutical practice.

Explore our services, stay updated on pharmacy trends, and join a community striving for innovation and professionalism in healthcare.

IMPORTANT INFORMATION

All content available on this website, including text, images, files, and other resources, is strictly protected under applicable copyright and intellectual property laws. Any reuse, reproduction, or redistribution of materials without prior written permission from Pharma Info Nepal is prohibited and may result in legal action.

Pharma Info Nepal operates as a registered company dedicated to maintaining the authenticity and integrity of its content and services.

Thank you for respecting our policies and supporting our mission to advance pharmacy education and practice.

CATEGORIES

  • B Pharmacy
  • Colleges
  • D Pharmacy
  • Downloads
  • License
  • Loksewa
  • M Pharmacy
  • Medicinal Chemistry
  • Notice
  • Nursing
  • Pharmacognosy
  • Pharmacology
  • Pharmacy Notes
  • Questions
  • Scholarship
  • Study Materials
  • Syllabus
  • Updates
  • Vacancy
  • Home
  • Vacancy
  • Courses
  • License
  • Loksewa
  • Questions
  • Downloads
  • Pharmacy Books
  • Pharmacy Notes

© 2026 Pharma Info Nepal Pvt. Ltd | All Rights Reserved

error:
No Result
View All Result
  • Home
  • Courses
  • Questions
  • Downloads
  • About Pharma Info Nepal 

© 2026 Pharma Info Nepal Pvt. Ltd | All Rights Reserved